Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mertens

Showing results (151-160 of 211) with videos related to

Pageof 22
Sort By:
Minerva Urology and Nephrology|February 20, 2023
Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registryJulien Sarkis, Romain Diamand, Fouad Aoun, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical CystectomyErik J van Gennep, Francesco Claps, Peter J Bostrom, et al.
BJU International|March 12, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancerMarkus von Deimling, Laura S Mertens, Marc Furrer, et al.
BJU International|March 13, 2026
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-upRoberto Contieri, Alberto Martini, Marc Furrer, et al.
BJU International|October 31, 2023
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancerMarkus von Deimling, Marc Furrer, Laura S Mertens, et al.
Journal of Autoimmunity|January 27, 2018
Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosisEleni Chouri, Nila H Servaas, Cornelis P J Bekker, et al.
European Urology Oncology|June 4, 2026
Sequential Imaging of Suspicion of Prostate Cancer: Reducing Overdiagnosis and Unnecessary Biopsy with Timely Diagnosis of Significant Cancer (SPROUT)-Prospective Multicentre Cohort Study ProtocolV Sweere, M de Rooij, P J M Kil, et al.
Rheumatology (Oxford, England)|August 19, 2020
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular riskJudith Wienke, Jorre S Mertens, Samuel Garcia, et al.
European Urology|August 25, 2024
Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient SelectionRoger Li, Patrick J Hensley, Shilpa Gupta, et al.
European Urology Oncology|June 21, 2024
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline PanelsLaura S Mertens, Harman Maxim Bruins, Roberto Contieri, et al.
Pageof 22

Showing results (151-160 of 211) with videos related to

Sort By:
Pageof 22
Minerva Urology and Nephrology|February 20, 2023
Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registryJulien Sarkis, Romain Diamand, Fouad Aoun, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical CystectomyErik J van Gennep, Francesco Claps, Peter J Bostrom, et al.
BJU International|March 12, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancerMarkus von Deimling, Laura S Mertens, Marc Furrer, et al.
BJU International|March 13, 2026
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-upRoberto Contieri, Alberto Martini, Marc Furrer, et al.
BJU International|October 31, 2023
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancerMarkus von Deimling, Marc Furrer, Laura S Mertens, et al.
Journal of Autoimmunity|January 27, 2018
Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosisEleni Chouri, Nila H Servaas, Cornelis P J Bekker, et al.
European Urology Oncology|June 4, 2026
Sequential Imaging of Suspicion of Prostate Cancer: Reducing Overdiagnosis and Unnecessary Biopsy with Timely Diagnosis of Significant Cancer (SPROUT)-Prospective Multicentre Cohort Study ProtocolV Sweere, M de Rooij, P J M Kil, et al.
Rheumatology (Oxford, England)|August 19, 2020
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular riskJudith Wienke, Jorre S Mertens, Samuel Garcia, et al.
European Urology|August 25, 2024
Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient SelectionRoger Li, Patrick J Hensley, Shilpa Gupta, et al.
European Urology Oncology|June 21, 2024
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline PanelsLaura S Mertens, Harman Maxim Bruins, Roberto Contieri, et al.
Pageof 22